• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钽棒植入联合带血管蒂骨移植治疗股骨头坏死:一项回顾性长期随访生存分析

The Combined Therapy of Tantalum Rod Implantation and Vascularized Bone Transplantation for Femoral Head Osteonecrosis: A Retrospective Long-Term Follow-Up Survival Analysis.

作者信息

Zhao Dewei, Cheng Liangliang, Yang Lei, Wang Benjie, Liu Baoyi

机构信息

Department of Orthopaedics, Affiliated Zhongshan Hospital of Dalian University, Dalian, China.

出版信息

Surg Technol Int. 2019 Nov 10;35:406-409.

PMID:31687779
Abstract

Tantalum rod implantation with vascularized bone transplantation has been reported to be an effective method for the treatment of osteonecrosis of the femoral head (ONFH). However, long-term follow-up results were unclear. Sixty-five patients (71 hips) with ONFH treated with this technique were retrospectively reviewed. According to the Association Research Circulation Osseous (ARCO) classification, 21 hips were stage II, 30 were stage III, and 15 were stage IV. Sixty-one patients (66 hips) were followed for more than 10 years. Fifteen hips had to be converted to total hip arthroplasty (THA), the proportion of THA conversion surgery over 10 years postoperative was 4.76% for stage II, 16.7% for stage III, and 60% for stage IV, respectively. The 10-year joint-preserving success rate of the entire group was 77.2%. The Harris Hip Score (HHS) in the patients not receiving THA therapy increased from a mean of 51.35 points (ranged from 32 to 62 points) to 90.12 points (ranged from 72 to 99 points). The technique of tantalum rod implantation with vascularized bone grafting was an effective joint-preserving method for the treatment of ARCO stage II-III ONFH.

摘要

钽棒植入联合带血管蒂骨移植已被报道是治疗股骨头坏死(ONFH)的一种有效方法。然而,长期随访结果尚不清楚。对采用该技术治疗的65例(71髋)ONFH患者进行了回顾性分析。根据骨循环研究协会(ARCO)分类,21髋为II期,30髋为III期,15髋为IV期。61例患者(66髋)随访超过10年。15髋不得不转换为全髋关节置换术(THA),术后10年THA转换手术的比例在II期为4.76%,III期为16.7%,IV期为60%。整个组的10年保髋成功率为77.2%。未接受THA治疗的患者的Harris髋关节评分(HHS)从平均51.35分(范围为32至62分)提高到90.12分(范围为72至99分)。钽棒植入联合带血管蒂骨移植技术是治疗ARCO II - III期ONFH的一种有效的保髋方法。

相似文献

1
The Combined Therapy of Tantalum Rod Implantation and Vascularized Bone Transplantation for Femoral Head Osteonecrosis: A Retrospective Long-Term Follow-Up Survival Analysis.钽棒植入联合带血管蒂骨移植治疗股骨头坏死:一项回顾性长期随访生存分析
Surg Technol Int. 2019 Nov 10;35:406-409.
2
Tantalum rod implantation and vascularized iliac grafting for osteonecrosis of the femoral head.钽棒植入术及带血管蒂髂骨移植治疗股骨头坏死
Orthopedics. 2013 Jun;36(6):789-95. doi: 10.3928/01477447-20130523-26.
3
Retrospective Long-Term Follow-Up Survival Analysis of the Management of Osteonecrosis of the Femoral Head With Pedicled Vascularized Iliac Bone Graft Transfer.带蒂血管化髂骨移植治疗股骨头坏死的回顾性长期随访生存分析。
J Arthroplasty. 2019 Aug;34(8):1585-1592. doi: 10.1016/j.arth.2019.03.069. Epub 2019 Apr 2.
4
Autologous bone marrow mesenchymal stem cells associated with tantalum rod implantation and vascularized iliac grafting for the treatment of end-stage osteonecrosis of the femoral head.自体骨髓间充质干细胞联合钽棒植入及带血管蒂髂骨移植治疗终末期股骨头坏死
Biomed Res Int. 2015;2015:240506. doi: 10.1155/2015/240506. Epub 2015 Feb 23.
5
Porous tantalum rod implantation is associated with low survival rates in patients with type C2 osteonecrosis of the femoral head but has no effect on the clinical outcome of conversion total hip arthroplasty: a retrospective study with an average 8-year follow-up.多孔钽棒植入与 C2 型股骨头坏死患者的低生存率相关,但对转换全髋关节置换术的临床结果无影响:一项平均 8 年随访的回顾性研究。
BMC Musculoskelet Disord. 2020 Dec 12;21(1):841. doi: 10.1186/s12891-020-03860-8.
6
Tantalum rod implantation for femoral head osteonecrosis: survivorship analysis and determination of prognostic factors for total hip arthroplasty.钽棒植入治疗股骨头坏死:全髋关节置换术的生存率分析及预后因素的确定
Int Orthop. 2016 Jul;40(7):1397-407. doi: 10.1007/s00264-015-2897-1. Epub 2015 Aug 11.
7
Long-term outcomes of Phemister bone grafting for patients with non-traumatic osteonecrosis of the femoral head.Phemister 骨移植治疗非创伤性股骨头坏死患者的长期疗效。
Int Orthop. 2019 Mar;43(3):579-587. doi: 10.1007/s00264-018-4013-9. Epub 2018 Jun 18.
8
One-sided hip-preserving and concurrent contralateral total hip arthroplasty for the treatment of bilateral osteonecrosis of the femoral head in different stages: short-medium term outcomes.一期保髋与同期对侧全髋关节置换术治疗不同阶段双侧股骨头坏死:中短期疗效
BMC Musculoskelet Disord. 2015 Jun 5;16:133. doi: 10.1186/s12891-015-0583-5.
9
[EFFECTIVENESS OF BONE GRAFTING THROUGH WINDOWING AT FEMORAL HEAD-NECK JUNCTION FOR TREATMENT OF OSTEONECROSIS WITH SEGMENTAL COLLAPSE OF FEMORAL HEAD].经股骨头颈交界处开窗植骨治疗股骨头节段性塌陷型骨坏死的疗效观察
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2016 Apr;30(4):397-401.
10
Real-time computerised tomography assisted porous tantalum implant in ARCO stage I-II non-traumatic osteonecrosis of the femoral head: minimum five-year follow up.实时计算机断层扫描辅助多孔钽植入治疗ARCO I-II期非创伤性股骨头坏死:至少五年随访
Int Orthop. 2018 Jul;42(7):1535-1544. doi: 10.1007/s00264-018-3899-6. Epub 2018 Mar 27.

引用本文的文献

1
Advancements in 3D printing technologies for personalized treatment of osteonecrosis of the femoral head.用于股骨头坏死个性化治疗的3D打印技术进展
Mater Today Bio. 2025 Feb 4;31:101531. doi: 10.1016/j.mtbio.2025.101531. eCollection 2025 Apr.
2
Bone tissue engineering for treating osteonecrosis of the femoral head.用于治疗股骨头坏死的骨组织工程
Exploration (Beijing). 2023 Feb 28;3(2):20210105. doi: 10.1002/EXP.20210105. eCollection 2023 Apr.
3
Local administration of zoledronic acid prevents traumatic osteonecrosis of the femoral head in rat model.
唑来膦酸局部给药可预防大鼠模型中的股骨头创伤性骨坏死。
J Orthop Translat. 2021 Mar 8;27:132-138. doi: 10.1016/j.jot.2020.08.005. eCollection 2021 Mar.